Navigation Links
Advances in drug screening: building a better haystack for the needles of tomorrow
Date:10/23/2007

SAN FRANCISCO With the discovery of suitable molecular targets cellular molecules along pathways crucial for sustaining the life of cancer cells comes the perplexing dilemma of where to find the next therapeutics that will bind to and disable those targets. While the possibilities for drug designs are near-limitless, the methods to screen drug databases and repositories are often problematic or ill-suited for the particular needs of researchers.

Today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, researchers report new means of delving into vast stores of data in search of potential therapies, whether to find the next natural cancer fighter or to discover new classes of therapeutics.

Targeting neuroblastoma tumor-initiating cells: High-throughput screening strategies to identify novel chemotherapeutics: Abstract A 205.

While research has yielded exceptional advances in treatment and therapeutics for most adult cancers, there has been little improvement in survival rates for patients with the deadly childhood cancer neuroblastoma for the past 30 years. Armed with advances in stem cell knowledge, researchers at The Hospital for Sick Children in Toronto, Canada, are screening currently approved drugs for new neuroblastoma therapies that kill cancer while sparing children exposure to excessive amounts of toxic therapeutics.

Using their screening process, the researchers searched more than 5,000 drugs and uncovered 47 candidates that show good potential against neuroblastoma, including rapamycin, on which the researchers are currently focusing.

Neuroblastoma is particularly difficult to treat without aggressive chemotherapy and, even when treated successfully, the chemotherapies currently in use frequently have side effects that can have devastating repercussions later in life, said Kristen Smith, Ph.D., a postdoctoral fellow at The Hospital for Sick Childre
'/>"/>

Contact: Greg Lester
greg.lester@aacr.org
267-646-0554
American Association for Cancer Research
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Advances in Treatment of Cataracts
2. Advances In Stem Cells Research
3. Speedier Access To Advances In Breast Cancer Sought For Patients
4. New Screening Techniques to Lead Advances In Pain Therapy
5. Advances Have Cut Combat Deaths in Iraq and Afghanistan
6. Prematurity More Accurately Predicted by Advances in Proteomic Technology
7. New DNA Tests Advances Treatment of Lysosomal Storage Diseases
8. Significant Advances in VCJD Prion Detection
9. Mislabeled Body-building Steroid Supplements
10. Training with weights helps building resistance
11. Milk Not So Good In Building Bones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...TSX: COM, VANCOUVER, July 23 /PRNewswire-FirstCal... today announced that it has entered into an,agree...ment fund managed by,CR Intrinsic Investors, LLC, ...rchase Series A convertible preferred shares for g...nancing will be used for general corporate,purpose...
(Date:7/23/2008)...ce the idea of using DNA to create faster, smaller...scientists have been scrambling to develop success... new research from a professor at Rensselaer Polyt... out artificial computations, all we have to do is... Cognitive Science Mark Changizi has begun to deve...
(Date:7/23/2008)..., July 23 /PRNewswire-USNewswire/ -- The Children,...e a generous $15 million,gift that will enable the...own, Pennsylvania. This gift, made possible by Ath...is one of the largest in the history of,Children,s...milies in the,nearby communities convenient access...
(Date:7/23/2008)...ly 23 /PRNewswire/ -- Times may be tough, but,Holl...there,s nothing like,a dazzling new smile to boost...DDS helps his celebrity clients beam in on success...ngs with it the self-confidence they,need for star...ting a new,high-wattage smile designed by Dr. Kosd...
Breaking Medicine News(10 mins):Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3Health News:Study suggests human visual system could make powerful computer 2Health News:Study suggests human visual system could make powerful computer 3Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 2Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 3Health News:Rock The Cradle's Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon 2
...rganization (WHO) the leading cause of maternal de...//, Africa and Latin America. Statistics show tha...omplications and over half a million die every yea...s department of reproductive health and research s...
...ril issue of Radiology says that ultrasound is the...women and also assess// the effectiveness of chemo...Center in Houston have just finished a study where... been diagnosed as well as treated for breast canc...
...eveloped in the US are at an advanced stage but it...he public, says an expert involved in the project....rt. There are large numbers of people involved and...esting methods. We are on the way but it will be a...
...haracterised by extreme and irrational fear of sim...not know exactly what causes this. // To overcome...hich is still in the trial stage. The remedy deve... team contains a human hormone called cortisol, wh...
Other Medicine News:Health News:Ultrasound Can Detect Breast Cancer in Pregnant Women 2Health News:HIV Vaccine Field Trials In Advanced Stage 2
(Date:7/23/2008)... ASPS Study Finds Some Areas of the Body Have G...IGHTS, Ill., July 23 /PRNewswire-USNewswire/ -- Fa...hrough liposuction was found to be,an excellent so...ations,than other areas of the body, reports a Bra...ructive Surgery(R), the official medical journal o...
(Date:7/23/2008)... SEATTLE, July 23 /- Den... that it expects the Independent Data,Monitoring C...rim analysis,of overall survival relating to the C...e AdenoCarcinoma Treatment, also known as D9902B) ...ENGE is the Company,s investigational,active cellu...
(Date:7/22/2008)... BRISBANE, Australia, July 22 /PRNewswire-First...d late yesterday, the Board of Progen,Pharmaceutic...ed that it,had discontinued the PI-88 phase 3 stud...direction to develop its existing portfolio of com...re additional compounds and,opportunities through ...
(Date:7/22/2008)... MINNEAPOLIS, July 22 /- Nonin Med...ing solutions for more than 20 years, has entered,...echnology to measure,regional oxygen saturation. T... is the continuous monitoring of the regional bloo... Early testing data and outcomes from an ongoing c...
Breaking Medicine Technology:Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2MEDdevice Acquisition Co LLC and Epsilon Securities LLC Identify Sources of Funding 21481 1MEDdevice Acquisition Co LLC and Epsilon Securities LLC Identify Sources of Funding 21481 2The Glazier Group Removes Tomatoes from Menus Nationwide 21478 1The Glazier Group Removes Tomatoes from Menus Nationwide 21478 2Oncolytics Biotech Inc Announces Start of Enrolment in Phase 1 2 Ovarian Cancer Clinical Trial with REOLYSIN 28R 29 5914 1Oncolytics Biotech Inc Announces Start of Enrolment in Phase 1 2 Ovarian Cancer Clinical Trial with REOLYSIN 28R 29 5914 2Oncolytics Biotech Inc Announces Start of Enrolment in Phase 1 2 Ovarian Cancer Clinical Trial with REOLYSIN 28R 29 5914 3Miltenyi Biotec GmbH Acquires Medic Tools AG 5911 1Miltenyi Biotec GmbH Acquires Medic Tools AG 5911 2
...tudy results show,that elevated lipoprotein-associ...specific inflammatory enzyme associated with,unsta...e, is,especially predictive of heart disease risk ... medical condition that affects nearly,50 million ...rday,at the American College of Cardiology,s annua...
...leveland Clinic,researchers today report that the ...oprotein cholesterol (HDL) or the "good",cholester...of,plaque buildup in the coronary arteries as meas....D., Chairman of Cardiovascular Medicine at,Clevel...trial, will,present the study on Monday, March 26 ...
Other Medicine Technology:Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 2Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 3Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 2Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 3Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 4
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: